1-3 of 3
Scott D. Nelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma

Anusha Kalbasi, Mitchell Kamrava, Fang-I Chu, Donatello Telesca, Ritchell Van Dams, Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah M. Dry, Jackie Hernandez, Bartosz Chmielowski, Arun S. Singh, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Joanne B. Weidhaas, Fritz C. Eilber
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (8): 1829–1836.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-3524
Published: 15 April 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

Daniel G. Branstetter, Scott D. Nelson, J. Carlos Manivel, Jean-Yves Blay, Sant Chawla, David M. Thomas, Susie Jun, Ira Jacobs
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (16): 4415–4424.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-0578
Published: 14 August 2012
View article
PDF
Includes: Supplementary data
Journal Articles

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

Vladimir Evilevitch, Wolfgang A. Weber, William D. Tap, Martin Allen-Auerbach, Kira Chow, Scott D. Nelson, Fredrick R. Eilber, Jeffery J. Eckardt, Robert M. Elashoff, Michael E. Phelps, Johannes Czernin, Fritz C. Eilber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 715–720.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-1762
Published: 01 February 2008
View article
PDF